From America On-Line:
I have searched medline and I have e-mailed to three international institutes that boast five-year successes and still going with islet cell transplants in patients who underwent simultaneous organ transplants for kidney and liver. So, theoretically, would you not agree that there have been some successes?
The possibility of having an islet cell transplant instead of a lifetime of injections, blood sugar tests and a long term threat of complications is immensely appealing not only to patients, but to a great many investigators. And yes, autografts, especially when given into the portal vein, seem to work fine, and whole pancreas transplants with a kidney transplant certainly extend life in diabetics with end-stage renal disease. Allografts also work where the pancreas has had to be removed; but require immunosuppression.
For young Type 1 Diabetics, islet cell transplants would have to be xenografts (that is, from another species), in order to meet the need. They also have to be encapsulated to avoid the need for long term immunosuppression and finally they have to be shown to work for an extended period of time. Progress has certainly been made; but real availability is still many years away. For the time being, it seems best not to overstate the case for transplants, and thereby to diminish the effort to achieve good control using intensive insulin therapy or a pump.
Original posting 5 Nov 96
|Return to the Top of This Page|
Last Updated: Tuesday April 06, 2010 15:08:52
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
© Children with Diabetes, Inc. 1995-2018. Comments and Feedback.